ECOG A Double-Blind Phase III Trial of Doxorubicin and Cyclophosphamide Followed by Paclitaxel with Bevacizumab or Placebo in Patients with Lymph Node Positive and High Risk Lymph Node Negative Breast Cancer Adult CIRB - Late Phase Emphasis Closed to Accrual. Pts Have Completed Intervention Available to Open